New research suggests that with high levels of vaccination and immunity from previous infections, COVID antivirals are no longer working as well.
Articles on Lagevrio
Displaying all articles
Two antiviral drugs are available in Australia, but one is prescribed more routinely. Here’s what you need to know as we navigate the eighth COVID wave.
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
People in disadvantaged communities are less likely to access COVID antivirals. That needs to change.
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.
Top contributors
-
PhD candidate, La Trobe University and Unit Head, Nossal Institute for Global Health, The University of Melbourne
-
Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Post doctoral researcher and medical epidemiologist, The Peter Doherty Institute for Infection and Immunity
-
Director and CEO, Burnet Institute
-
Professor of Public Health, La Trobe University
-
Professor of Infectious Diseases, Monash University
-
PhD Candidate, Vaccines and Antiviral Effectiveness, UNSW
-
Professor, UNSW
-
Head of School of Population Health and Professor, Infectious Diseases Dynamics and Interventions, UNSW